Platelet Transfusion in Cardiac Surgery Does Not Confer Increased Risk for Adverse Morbid Outcomes

Annals of Thoracic Surgery

Volumn 86, Issue 2, 2008, Pages 543-553

  McGrath, Tory ^a   Koch, Colleen Gorman ^a   Xu, Meng ^a   Li, Liang ^a   Mihaljevic, Tomislav ^a   Figueroa, Priscilla ^a   Blackstone, Eugene H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR PROCEDURES; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; ERYTHROCYTE TRANSFUSION; FEMALE; HEART DISEASE; HEART SURGERY; HEART VALVE; HUMAN; INFECTION; KIDNEY DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; SURGICAL RISK; THROMBOCYTE; THROMBOCYTE TRANSFUSION; UNIVARIATE ANALYSIS;

AGED; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; COMORBIDITY; FEMALE; HEART DISEASES; HEART VALVE DISEASES; HOSPITAL MORTALITY; HUMANS; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLATELET TRANSFUSION; RISK ASSESSMENT;

EID: 47149109677     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2008.04.051     Document Type: Article

References (28)

1. Harker L.A., Malpass T.W., Branson H.E., Hessel E.A., and Slichter S.J. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release. Blood 56 (1980) 824-834
2. Cobain T.J., Vamvakas E.C., Wells A., and Titlestad K. A survey of the demographics of blood use. Transfusion Medicine 17 (2007) 1-15
3. Goodnough L.T., Johnston M.F., and Toy P.T. The variability of transfusion practice in coronary artery bypass surgery. Transfusion Medicine Academic Award Group. JAMA 265 (1991) 86-90
4. Ferraris V.A., Ferraris S.P., Saha S.P., et al., Society of Thoracic Surgeons Blood Conservation Guideline Task Force. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists clinical practice guideline. Spiess BD, Shore-Lesserson L, Stafford-Smith M, et al., Society of Cardiovascular Anesthesiologists Special Task Force on Blood Transfusion. Ann Thorac Surg 83 5 suppl (2007) 27-86
5. Vamvakas E.C., and Carven J.H. Allogeneic blood transfusion and postoperative duration of mechanical ventilation: effects of red cell supernatant, platelet supernatant, plasma components, and total transfused fluid. Vox Sang 82 (2002) 141-149
6. Spiess B.D., Royston D., Levy J.H., et al. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion 44 (2004) 1143-1148
7. Sreeram G.M., Welsby I.J., Sharma A.D., et al. Infectious complications after cardiac surgery: lack of association with fresh frozen plasma or platelet transfusions. J Cardiothorac Vasc Anesth 19 (2005) 430-434
8. Karkouti K., Wijeysundera D.N., Yau T.M., et al. Platelet transfusions are not associated with increased morbidity or mortality in cardiac surgery. Can J Anesth 53 (2006) 279-287
9. Vamvakas E.C. Platelet transfusion and postoperative infection in cardiac surgery. Transfusion 47 (2007) 352-354
10. Koch C.G., Li L., Duncan A.I., et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med 34 (2006) 1608-1616
11. Koch C.G., Li L., Duncan A.I., et al. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg 81 (2006) 1650-1657
12. Rosenbaum P., and Rubin D.B. The central role of the propensity score in observational studies for causal effects. Biometrika 70 (1983) 41-55
13. Parson L. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. Proceedings of 26th Annual SAS Users Group International Conference (2001) 214-216
14. Michalopoulos A., Tzelepis G., Dafni U., and Geroulanos S. Determinants of hospital mortality after coronary artery bypass grafting. Chest 115 (1999) 1598-1603
15. Mangano D.T., Tudor J.C., Dietzel C., and Multicenter Study of Perioperative Ischemia (McSPI) Research Group and the Ischemia Research and Education Foundation. The risk associated with aprotinin in cardiac surgery. N Engl J Med 354 (2006) 353-365
16. Karkouti K., Beattie W.S., Dattilo K.M., et al. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion 46 (2006) 327-338
17. Mangano D.T., Miao Y., Vuylsteke A., et al., Investigators of the Multicenter Study of Perioperative Ischemia Group and the Ischemia Research and Education Foundation. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 297 (2007) 471-479
18. Bhanot S., and Alex J.C. Current applications of platelet gels in facial plastic surgery. Facial Plast Surg 18 (2002) 27-33
19. Anitua E., Andia I., Ardanza B., Nurden P., and Nurden A.T. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 91 (2004) 4-15
20. Buckwalter J.A., Einhorn T.A., Bolander M.E., et al. Healing of musculoskeletal tissues. In: Rockwood Jr. C.A., Bucholz R.W., and Green D.P. (Eds). Fractures in adults (1996), Lippincott-Raven, Philadelphia, PA 261-304
21. Marx R.E. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 62 (2004) 489-496
22. Eppley B.L., Pietrzak W.S., and Blanton M. Platelet-rich plasma: a review of biology and applications in plastic surgery. Plast Reconstr Surg 118 (2006) 147e-159e
23. DelRossi A.J., Cernaianu A.C., Vertrees R.A., et al. Platelet-rich plasma reduces postoperative blood loss after cardiopulmonary bypass. J Thorac Cardiovasc Surg 100 (1990) 281-286
24. Wajon P., Gibson J., Calcroft R., Hughes C., Hughes C., and Thrift B. Intraoperative plateletpheresis and autologous platelet gel do not reduce chest tube drainage or allogeneic blood transfusion after reoperative coronary artery bypass graft. Anesth Analg 93 (2001) 536-542
25. Bilgin Y.M., van de Watering L.M., Eijsman L., et al. Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusion in cardiac valve surgery. Circulation 109 (2004) 2755-2760
26. Wallis J.P., Chapman C.E., Orr K.E., Clark S.C., and Forty J.R. Effect of WBC reduction of transfused RBCs on post-operative infection rates in cardiac surgery. Transfusion 42 (2002) 1127-1134
27. van de Watering L.M., Hermans J., Houbiers J.G., et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 97 (1998) 562-568
28. Blajchman M.A. The clinical benefits of the leukoreduction of blood products. J Trauma 60 6 suppl (2006) S83-S90